Bridglal Ramkissoon in Sebring, Florida

Medical School: Sorry, his university is not listed
Graduation Year: 1991
The Primary Medical Specialty for Bridglal Ramkissoon is listed as: Neurology
Approximate Years of Experience: 33
PAC (PECOS ID)#: 9830381441
NPI #: 1639110018
NPI Created On: 06/09/2006
NPI Last Updated Listed as: 11/24/2010
Primary Taxonomy Code: 2084N0400X
License Number:
ME74590
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Measurement and recording of brain wave (eeg) activity, awake and drowsy
2. Needle measurement and recording of electrical activity of muscles of arm or leg complete study
3. Nerve transmission studies, 3-4 studies
4. Nerve transmission studies, 5-6 studies
5. Nerve transmission studies, 7-8 studies
6. New patient office or other outpatient visit, typically 30 minutes
7. New patient office or other outpatient visit, typically 45 minutes
8. Established patient office or other outpatient visit, typically 15 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Hospital observation care, typically 50 minutes
11. Initial hospital inpatient care, typically 50 minutes per day
12. Initial hospital inpatient care, typically 70 minutes per day
13. Subsequent observation care, typically 15 minutes per day
14. Subsequent hospital inpatient care, typically 15 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.